PharmaTox
The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
News
-
New PhD in Perinatal Pharmacopidemiology!
Sep. 30, 2021 4:59 PM
PharmaTox PhD student Sarah Hjorth Andersen has defended her doctoral thesis "Childhood outcomes after prenatal exposure to analgesics or antibiotics". Congratulations!
-
New master's thesis!
Aug. 19, 2021 4:30 PM
Ingliv Gjetmundsen defended her master's thesis in June 2021. Congratulations!
-
Ny PharmaSafe-artikkel publisert!
Aug. 11, 2021 10:26 PM
Ny artikkel fra PharmaSafe oppsummerer hva vi vet om medisinbruk i svangerskapet og risiko for barnekreft.
-
Welcome, Mostafa Alwash!
Aug. 6, 2021 10:03 PM
We welcome Mostafa Alwash as a new postdoc of PharmaTox. He presents himself below.
-
New article from PharmaTox summarises the research on prenatal medication exposure and offspring epigenetic outcomes
June 22, 2021 8:38 PM
